Companies / Galecto, Inc.
Galecto, Inc.
Nasdaq: DMRAGLTOCIK 1800315WALTHAM, MA
Financials
Ownership
61.7M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 15.08% | 9,312,504 |
| Public float | 84.92% | 52,423,015 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Fairmount Funds Management LLCDirector · 10% owner | 14.11% | 8,713,000 |
Hewes L. BeckerChief Medical Officer | 0.43% | 264,629 |
Sattarzadeh SherwinChief Operating Officer | 0.31% | 190,376 |
Bruno JulianneDirector | 0.22% | 137,032 |
Schambye Hans T.CEOChief Executive Officer · Director | <0.01% | 4,682 |
Winslow GarrettGeneral Counsel | <0.01% | 1,854 |
Firmani LoriChief Financial Officer | <0.01% | 931 |
Cain Christopher W.Director | — | — |
Fairmount Healthcare Co-Invest V L.P.Director · 10% owner | — | — |
Fairmount Healthcare Fund II L.P.Director · 10% owner | — | — |
Institutional holders 0
| Holder | Value | % of shares |
|---|---|---|
| No institutional holders on file. | ||
Activity
InsidersInstitutions
Who's accumulating and trimming this stock (13F).No activity matches these filters.
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | Passive13G | — |
| Ikarian Capital, LLC | Passive13G/A | — |
| Paragon Therapeutics, Inc. | Passive13G | — |
| Paramora Holding LLC | Passive13G | — |
| Jain Global LLC | Passive13G | — |